APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spermicides

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Spermicides Industry Growth and Trends Forecast to 2032

29 December 2025104 pages

Choose your research edition.

Industry ResearchSpermicides Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Spermicides Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Spermicides Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spermicides Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Spermicides Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Spermicides market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spermicides is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Spermicides include Advantage-S, Conceptrol, Crinone, Delfen Foam, Emko, Encare, Endometrin, First-Progesterone VGS and Gynol II, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Spermicides market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Spermicides market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Spermicides market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Spermicides.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Spermicides market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Spermicides Market by Company

Advantage-S

Conceptrol

Crinone

Delfen Foam

Emko

Encare

Endometrin

First-Progesterone VGS

Gynol II

Phexxi

Prochieve

Spermicides Segment by Type

Suppositories

Creams

Foams

Gels

Film

Spermicides Segment by Application

Online Pharmacies

Retail Pharmacies

Hospital

Spermicides Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spermicides market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spermicides and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spermicides.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Spermicides manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Spermicides in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Suppositories Table 2. Major Company of Creams Table 3. Major Company of Foams Table 4. Major Company of Gels Table 5. Major Company of Film Table 6. Global Spermicides Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Spermicides Sales by Type (2021-2026) & (K Units) Table 8. Global Spermicides Sales Market Share in Volume by Type (2021-2026) Table 9. Global Spermicides Sales by Type (2021-2026) & (US$ Million) Table 10. Global Spermicides Sales Market Share in Value by Type (2021-2026) Table 11. Global Spermicides Price by Type (2021-2026) & (US$/Unit) Table 12. Global Spermicides Sales by Type (2027-2032) & (K Units) Table 13. Global Spermicides Sales Market Share in Volume by Type (2027-2032) Table 14. Global Spermicides Sales by Type (2027-2032) & (US$ Million) Table 15. Global Spermicides Sales Market Share in Value by Type (2027-2032) Table 16. Global Spermicides Price by Type (2027-2032) & (US$/Unit) Table 17. North America Spermicides Sales by Type (2021-2026) & (K Units) Table 18. North America Spermicides Sales by Type (2021-2026) & (US$ Million) Table 19. Europe Spermicides Sales by Type (2021-2026) & (K Units) Table 20. Europe Spermicides Sales by Type (2021-2026) & (US$ Million) Table 21. Asia-Pacific Spermicides Sales by Type (2021-2026) & (K Units) Table 22. Asia-Pacific Spermicides Sales by Type (2021-2026) & (US$ Million) Table 23. Latin America Spermicides Sales by Type (2021-2026) & (K Units) Table 24. Latin America Spermicides Sales by Type (2021-2026) & (US$ Million) Table 25. Middle East and Africa Spermicides Sales by Type (2021-2026) & (K Units) Table 26. Middle East and Africa Spermicides Sales by Type (2021-2026) & (US$ Million) Table 27. Spermicides Industry Trends Table 28. Spermicides Industry Drivers Table 29. Spermicides Industry Opportunities and Challenges Table 30. Spermicides Industry Restraints Table 31. Global Spermicides Sales Revenue by Company (US$ Million) & (2021-2026) Table 32. Global Spermicides Revenue Market Share by Company (2021-2026) Table 33. Global Spermicides Sales by Company (2021-2026) & (K Units) Table 34. Global Spermicides Sales Share by Company (2021-2026) Table 35. Global Spermicides Market Price by Company (2021-2026) & (US$/Unit) Table 36. Global Spermicides Industry Company Ranking, 2024 VS 2025 VS 2026 Table 37. Global Spermicides Major Company Production Sites and Headquarters Table 38. Global Spermicides Company, Product Type & Application Table 39. Global Spermicides Company Establishment Date Table 40. Global Company Market Concentration Ratio (CR5 and HHI) Table 41. Global Spermicides by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 42. Global Spermicides Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 43. Global Spermicides Sales by Region (2021-2026) & (K Units) Table 44. Global Spermicides Sales Market Share in Volume by Region (2021-2026) Table 45. Global Spermicides Sales by Region (2021-2026) & (US$ Million) Table 46. Global Spermicides Sales Market Share in Value by Region (2021-2026) Table 47. Global Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 48. Global Spermicides Sales by Region (2027-2032) & (K Units) Table 49. Global Spermicides Sales Market Share in Volume by Region (2027-2032) Table 50. Global Spermicides Sales by Region (2027-2032) & (US$ Million) Table 51. Global Spermicides Sales Market Share in Value by Region (2027-2032) Table 52. Global Spermicides Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 53. Global Spermicides Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 54. Global Spermicides Sales by Application (2021-2026) & (K Units) Table 55. Global Spermicides Sales Market Share in Volume by Application (2021-2026) Table 56. Global Spermicides Sales by Application (2021-2026) & (US$ Million) Table 57. Global Spermicides Sales Market Share in Value by Application (2021-2026) Table 58. Global Spermicides Price by Application (2021-2026) & (US$/Unit) Table 59. Global Spermicides Sales by Application (2027-2032) & (K Units) Table 60. Global Spermicides Sales Market Share in Volume by Application (2027-2032) Table 61. Global Spermicides Sales by Application (2027-2032) & (US$ Million) Table 62. Global Spermicides Sales Market Share in Value by Application (2027-2032) Table 63. Global Spermicides Price by Application (2027-2032) & (US$/Unit) Table 64. North America Spermicides Sales by Application (2021-2026) & (K Units) Table 65. North America Spermicides Sales by Application (2021-2026) & (US$ Million) Table 66. Europe Spermicides Sales by Application (2021-2026) & (K Units) Table 67. Europe Spermicides Sales by Application (2021-2026) & (US$ Million) Table 68. Asia-Pacific Spermicides Sales by Application (2021-2026) & (K Units) Table 69. Asia-Pacific Spermicides Sales by Application (2021-2026) & (US$ Million) Table 70. Latin America Spermicides Sales by Application (2021-2026) & (K Units) Table 71. Latin America Spermicides Sales by Application (2021-2026) & (US$ Million) Table 72. Middle East and Africa Spermicides Sales by Application (2021-2026) & (K Units) Table 73. Middle East and Africa Spermicides Sales by Application (2021-2026) & (US$ Million) Table 74. Advantage-S Company Information Table 75. Advantage-S Business Overview Table 76. Advantage-S Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Advantage-S Spermicides Product Portfolio Table 78. Advantage-S Recent Development Table 79. Conceptrol Company Information Table 80. Conceptrol Business Overview Table 81. Conceptrol Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Conceptrol Spermicides Product Portfolio Table 83. Conceptrol Recent Development Table 84. Crinone Company Information Table 85. Crinone Business Overview Table 86. Crinone Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Crinone Spermicides Product Portfolio Table 88. Crinone Recent Development Table 89. Delfen Foam Company Information Table 90. Delfen Foam Business Overview Table 91. Delfen Foam Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Delfen Foam Spermicides Product Portfolio Table 93. Delfen Foam Recent Development Table 94. Emko Company Information Table 95. Emko Business Overview Table 96. Emko Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Emko Spermicides Product Portfolio Table 98. Emko Recent Development Table 99. Encare Company Information Table 100. Encare Business Overview Table 101. Encare Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Encare Spermicides Product Portfolio Table 103. Encare Recent Development Table 104. Endometrin Company Information Table 105. Endometrin Business Overview Table 106. Endometrin Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Endometrin Spermicides Product Portfolio Table 108. Endometrin Recent Development Table 109. First-Progesterone VGS Company Information Table 110. First-Progesterone VGS Business Overview Table 111. First-Progesterone VGS Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. First-Progesterone VGS Spermicides Product Portfolio Table 113. First-Progesterone VGS Recent Development Table 114. Gynol II Company Information Table 115. Gynol II Business Overview Table 116. Gynol II Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Gynol II Spermicides Product Portfolio Table 118. Gynol II Recent Development Table 119. Phexxi Company Information Table 120. Phexxi Business Overview Table 121. Phexxi Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Phexxi Spermicides Product Portfolio Table 123. Phexxi Recent Development Table 124. Prochieve Company Information Table 125. Prochieve Business Overview Table 126. Prochieve Spermicides Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Prochieve Spermicides Product Portfolio Table 128. Prochieve Recent Development Table 129. North America Spermicides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 130. North America Spermicides Sales by Country (2021-2026) & (K Units) Table 131. North America Spermicides Sales Market Share by Country (2021-2026) Table 132. North America Spermicides Sales Forecast by Country (2027-2032) & (K Units) Table 133. North America Spermicides Sales Market Share Forecast by Country (2027-2032) Table 134. North America Spermicides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 135. North America Spermicides Market Size by Country (2021-2026) & (US$ Million) Table 136. North America Spermicides Market Share by Country (2021-2026) Table 137. North America Spermicides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 138. North America Spermicides Market Share Forecast by Country (2027-2032) Table 139. Europe Spermicides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 140. Europe Spermicides Sales by Country (2021-2026) & (K Units) Table 141. Europe Spermicides Sales Market Share by Country (2021-2026) Table 142. Europe Spermicides Sales Forecast by Country (2027-2032) & (K Units) Table 143. Europe Spermicides Sales Market Share Forecast by Country (2027-2032) Table 144. Europe Spermicides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 145. Europe Spermicides Market Size by Country (2021-2026) & (US$ Million) Table 146. Europe Spermicides Market Share by Country (2021-2026) Table 147. Europe Spermicides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 148. Europe Spermicides Market Share Forecast by Country (2027-2032) Table 149. Asia-Pacific Spermicides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 150. Asia-Pacific Spermicides Sales by Country (2021-2026) & (K Units) Table 151. Asia-Pacific Spermicides Sales Market Share by Country (2021-2026) Table 152. Asia-Pacific Spermicides Sales Forecast by Country (2027-2032) & (K Units) Table 153. Asia-Pacific Spermicides Sales Market Share Forecast by Country (2027-2032) Table 154. Asia-Pacific Spermicides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 155. Asia-Pacific Spermicides Market Size by Country (2021-2026) & (US$ Million) Table 156. Asia-Pacific Spermicides Market Share by Country (2021-2026) Table 157. Asia-Pacific Spermicides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 158. Asia-Pacific Spermicides Market Share Forecast by Country (2027-2032) Table 159. Latin America Spermicides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 160. Latin America Spermicides Sales by Country (2021-2026) & (K Units) Table 161. Latin America Spermicides Sales Market Share by Country (2021-2026) Table 162. Latin America Spermicides Sales Forecast by Country (2027-2032) & (K Units) Table 163. Latin America Spermicides Sales Market Share Forecast by Country (2027-2032) Table 164. Latin America Spermicides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 165. Latin America Spermicides Market Size by Country (2021-2026) & (US$ Million) Table 166. Latin America Spermicides Market Share by Country (2021-2026) Table 167. Latin America Spermicides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 168. Latin America Spermicides Market Share Forecast by Country (2027-2032) Table 169. Middle East and Africa Spermicides Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 170. Middle East and Africa Spermicides Sales by Country (2021-2026) & (K Units) Table 171. Middle East and Africa Spermicides Sales Market Share by Country (2021-2026) Table 172. Middle East and Africa Spermicides Sales Forecast by Country (2027-2032) & (K Units) Table 173. Middle East and Africa Spermicides Sales Market Share Forecast by Country (2027-2032) Table 174. Middle East and Africa Spermicides Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 175. Middle East and Africa Spermicides Market Size by Country (2021-2026) & (US$ Million) Table 176. Middle East and Africa Spermicides Market Share by Country (2021-2026) Table 177. Middle East and Africa Spermicides Market Size Forecast by Country (2027-2032) & (US$ Million) Table 178. Middle East and Africa Spermicides Market Share Forecast by Country (2027-2032) Table 179. Key Raw Materials Table 180. Raw Materials Key Suppliers Table 181. Spermicides Distributors List Table 182. Spermicides Customers List Table 183. Research Programs/Design for This Report Table 184. Authors List of This Report Table 185. Secondary Sources Table 186. Primary Sources List of Figures Figure 1. Spermicides Image Figure 2. Global Spermicides Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spermicides Market Size (2021-2032) & (US$ Million) Figure 4. Global Spermicides Sales (2021-2032) & (K Units) Figure 5. Suppositories Image Figure 6. Global Suppositories Sales YoY Growth (2021-2032) & (K Units) Figure 7. Creams Image Figure 8. Global Creams Sales YoY Growth (2021-2032) & (K Units) Figure 9. Foams Image Figure 10. Global Foams Sales YoY Growth (2021-2032) & (K Units) Figure 11. Gels Image Figure 12. Global Gels Sales YoY Growth (2021-2032) & (K Units) Figure 13. Film Image Figure 14. Global Film Sales YoY Growth (2021-2032) & (K Units) Figure 15. Global Spermicides Market Size Overview by Type (2021-2032) & (US$ Million) Figure 16. Global Spermicides Market Share by Type 2025 VS 2032 Figure 17. North America Spermicides Sales Market Share in Volume by Type in 2025 Figure 18. North America Spermicides Sales Market Share in Value by Type in 2025 Figure 19. Europe Spermicides Sales Market Share in Volume by Type in 2025 Figure 20. Europe Spermicides Sales Market Share in Value by Type in 2025 Figure 21. Asia-Pacific Spermicides Sales Market Share in Volume by Type in 2025 Figure 22. Asia-Pacific Spermicides Sales Market Share in Value by Type in 2025 Figure 23. Latin America Spermicides Sales Market Share in Volume by Type in 2025 Figure 24. Latin America Spermicides Sales Market Share in Value by Type in 2025 Figure 25. Middle East and Africa Spermicides Sales Market Share in Volume by Type in 2025 Figure 26. Middle East and Africa Spermicides Sales Market Share in Value by Type in 2025 Figure 27. Global Top 5 and 10 Spermicides Players Market Share by Revenue in 2025 Figure 28. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Online Pharmacies Image Figure 30. Global Online Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 31. Retail Pharmacies Image Figure 32. Global Retail Pharmacies Sales YoY Growth (2021-2032) & (K Units) Figure 33. Hospital Image Figure 34. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 35. Global Spermicides Market Size Overview by Application (2021-2032) & (US$ Million) Figure 36. Global Spermicides Market Share by Application 2025 VS 2032 Figure 37. North America Spermicides Sales Market Share in Volume by Application in 2025 Figure 38. North America Spermicides Sales Market Share in Value by Application in 2025 Figure 39. Europe Spermicides Sales Market Share in Volume by Application in 2025 Figure 40. Europe Spermicides Sales Market Share in Value by Application in 2025 Figure 41. Asia-Pacific Spermicides Sales Market Share in Volume by Application in 2025 Figure 42. Asia-Pacific Spermicides Sales Market Share in Value by Application in 2025 Figure 43. Latin America Spermicides Sales Market Share in Volume by Application in 2025 Figure 44. Latin America Spermicides Sales Market Share in Value by Application in 2025 Figure 45. Middle East and Africa Spermicides Sales Market Share in Volume by Application in 2025 Figure 46. Middle East and Africa Spermicides Sales Market Share in Value by Application in 2025 Figure 47. North America Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. North America Spermicides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. North America Spermicides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. North America Spermicides Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Europe Spermicides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Spermicides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Europe Spermicides Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Asia-Pacific Spermicides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Asia-Pacific Spermicides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Asia-Pacific Spermicides Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Latin America Spermicides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Latin America Spermicides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Latin America Spermicides Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Spermicides Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 64. Middle East and Africa Spermicides Sales Share by Country: 2021 VS 2025 VS 2032 Figure 65. Middle East and Africa Spermicides Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 66. Middle East and Africa Spermicides Market Share by Country: 2021 VS 2025 VS 2032 Figure 67. Spermicides Value Chain Figure 68. Key Raw Materials Price Figure 69. Manufacturing Cost Structure Figure 70. Spermicides Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Suppositories
  • Creams
  • Foams
  • Gels
  • Film
Applications
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital
Companies covered
  • Advantage-S
  • Conceptrol
  • Crinone
  • Delfen Foam
  • Emko
  • Encare
  • Endometrin
  • First-Progesterone VGS
  • Gynol II
  • Phexxi
  • Prochieve

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Spermicides Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Spermicides Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Spermicides Market by Type
  6. 1.3.1 Suppositories
  7. 1.3.2 Creams
  8. 1.3.3 Foams
  9. 1.3.4 Gels
  10. 1.3.5 Film
  11. 1.4 Global Spermicides Market Size by Type
  12. 1.4.1 Global Spermicides Market Size Overview by Type (2021-2032)
  13. 1.4.2 Global Spermicides Historic Market Size Review by Type (2021-2026)
  14. 1.4.3 Global Spermicides Forecasted Market Size by Type (2027-2032)
  15. 1.5 Key Regions Market Size by Type
  16. 1.5.1 North America Spermicides Sales Breakdown by Type (2021-2026)
  17. 1.5.2 Europe Spermicides Sales Breakdown by Type (2021-2026)
  18. 1.5.3 Asia-Pacific Spermicides Sales Breakdown by Type (2021-2026)
  19. 1.5.4 South America Spermicides Sales Breakdown by Type (2021-2026)
  20. 1.5.5 Middle East and Africa Spermicides Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Spermicides Industry Trends
  2. 2.2 Spermicides Industry Drivers
  3. 2.3 Spermicides Industry Opportunities and Challenges
  4. 2.4 Spermicides Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Spermicides Revenue (2021-2026)
  2. 3.2 Global Top Players by Spermicides Sales (2021-2026)
  3. 3.3 Global Top Players by Spermicides Price (2021-2026)
  4. 3.4 Global Spermicides Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Spermicides Major Company Production Sites & Headquarters
  6. 3.6 Global Spermicides Company, Product Type & Application
  7. 3.7 Global Spermicides Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Spermicides Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Spermicides Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Spermicides Tier 1, Tier 2, and Tier 3
4 Spermicides Regional Status and Outlook
  1. 4.1 Global Spermicides Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Spermicides Historic Market Size by Region
  3. 4.2.1 Global Spermicides Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Spermicides Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Spermicides Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Spermicides Forecasted Market Size by Region
  7. 4.3.1 Global Spermicides Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Spermicides Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Spermicides Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Spermicides by Application
  1. 5.1 Spermicides Market by Application
  2. 5.1.1 Online Pharmacies
  3. 5.1.2 Retail Pharmacies
  4. 5.1.3 Hospital
  5. 5.2 Global Spermicides Market Size by Application
  6. 5.2.1 Global Spermicides Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Spermicides Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Spermicides Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Spermicides Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Spermicides Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Spermicides Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Spermicides Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Spermicides Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Advantage-S
  2. 6.1.1 Advantage-S Company Information
  3. 6.1.2 Advantage-S Business Overview
  4. 6.1.3 Advantage-S Spermicides Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Advantage-S Spermicides Product Portfolio
  6. 6.1.5 Advantage-S Recent Developments
  7. 6.2 Conceptrol
  8. 6.2.1 Conceptrol Company Information
  9. 6.2.2 Conceptrol Business Overview
  10. 6.2.3 Conceptrol Spermicides Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Conceptrol Spermicides Product Portfolio
  12. 6.2.5 Conceptrol Recent Developments
  13. 6.3 Crinone
  14. 6.3.1 Crinone Company Information
  15. 6.3.2 Crinone Business Overview
  16. 6.3.3 Crinone Spermicides Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Crinone Spermicides Product Portfolio
  18. 6.3.5 Crinone Recent Developments
  19. 6.4 Delfen Foam
  20. 6.4.1 Delfen Foam Company Information
  21. 6.4.2 Delfen Foam Business Overview
  22. 6.4.3 Delfen Foam Spermicides Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Delfen Foam Spermicides Product Portfolio
  24. 6.4.5 Delfen Foam Recent Developments
  25. 6.5 Emko
  26. 6.5.1 Emko Company Information
  27. 6.5.2 Emko Business Overview
  28. 6.5.3 Emko Spermicides Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Emko Spermicides Product Portfolio
  30. 6.5.5 Emko Recent Developments
  31. 6.6 Encare
  32. 6.6.1 Encare Company Information
  33. 6.6.2 Encare Business Overview
  34. 6.6.3 Encare Spermicides Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Encare Spermicides Product Portfolio
  36. 6.6.5 Encare Recent Developments
  37. 6.7 Endometrin
  38. 6.7.1 Endometrin Company Information
  39. 6.7.2 Endometrin Business Overview
  40. 6.7.3 Endometrin Spermicides Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Endometrin Spermicides Product Portfolio
  42. 6.7.5 Endometrin Recent Developments
  43. 6.8 First-Progesterone VGS
  44. 6.8.1 First-Progesterone VGS Company Information
  45. 6.8.2 First-Progesterone VGS Business Overview
  46. 6.8.3 First-Progesterone VGS Spermicides Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 First-Progesterone VGS Spermicides Product Portfolio
  48. 6.8.5 First-Progesterone VGS Recent Developments
  49. 6.9 Gynol II
  50. 6.9.1 Gynol II Company Information
  51. 6.9.2 Gynol II Business Overview
  52. 6.9.3 Gynol II Spermicides Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Gynol II Spermicides Product Portfolio
  54. 6.9.5 Gynol II Recent Developments
  55. 6.10 Phexxi
  56. 6.10.1 Phexxi Company Information
  57. 6.10.2 Phexxi Business Overview
  58. 6.10.3 Phexxi Spermicides Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Phexxi Spermicides Product Portfolio
  60. 6.10.5 Phexxi Recent Developments
  61. 6.11 Prochieve
  62. 6.11.1 Prochieve Company Information
  63. 6.11.2 Prochieve Business Overview
  64. 6.11.3 Prochieve Spermicides Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Prochieve Spermicides Product Portfolio
  66. 6.11.5 Prochieve Recent Developments
7 North America by Country
  1. 7.1 North America Spermicides Sales by Country
  2. 7.1.1 North America Spermicides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Spermicides Sales by Country (2021-2026)
  4. 7.1.3 North America Spermicides Sales Forecast by Country (2027-2032)
  5. 7.2 North America Spermicides Market Size by Country
  6. 7.2.1 North America Spermicides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Spermicides Market Size by Country (2021-2026)
  8. 7.2.3 North America Spermicides Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Spermicides Sales by Country
  2. 8.1.1 Europe Spermicides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Spermicides Sales by Country (2021-2026)
  4. 8.1.3 Europe Spermicides Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Spermicides Market Size by Country
  6. 8.2.1 Europe Spermicides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Spermicides Market Size by Country (2021-2026)
  8. 8.2.3 Europe Spermicides Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Spermicides Sales by Country
  2. 9.1.1 Asia-Pacific Spermicides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Spermicides Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Spermicides Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Spermicides Market Size by Country
  6. 9.2.1 Asia-Pacific Spermicides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Spermicides Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Spermicides Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Spermicides Sales by Country
  2. 10.1.1 South America Spermicides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Spermicides Sales by Country (2021-2026)
  4. 10.1.3 South America Spermicides Sales Forecast by Country (2027-2032)
  5. 10.2 South America Spermicides Market Size by Country
  6. 10.2.1 South America Spermicides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Spermicides Market Size by Country (2021-2026)
  8. 10.2.3 South America Spermicides Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Spermicides Sales by Country
  2. 11.1.1 Middle East and Africa Spermicides Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Spermicides Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Spermicides Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Spermicides Market Size by Country
  6. 11.2.1 Middle East and Africa Spermicides Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Spermicides Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Spermicides Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Spermicides Value Chain Analysis
  2. 12.1.1 Spermicides Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Spermicides Production Mode & Process
  7. 12.2 Spermicides Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Spermicides Distributors
  10. 12.2.3 Spermicides Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst